Clinical investigation of medicinal products for the treatment of juvenile idiopathic arthritis

  • Email
  • Help
Current effective version

Revision 2 - Adopted guideline

Reference numberEMA/CHMP/239770/2014 Rev. 2
Published20/11/2015
Effective from01/06/2016
KeywordsJuvenile idiopathic arthritis, systemic juvenile idiopatic arthritis, oligoarthritis, polyarthritis, enthesitis related arthritis, extrapolation
DescriptionThis document provides guidelines for the evaluation of medicinal products in juvenile idiopathic arthritis. It addresses specific issues related to the design of clinical studies, extrapolation of efficacy from other age groups and corresponding arthritis diagnoses, and assessment of disease activity.


Document history

Revision 2 

Current version
 

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/06/2016


Published: 27/11/2015


Published: 15/05/2014


Published: 28/09/2012

First version

 

Adopted guideline


Overview of comments


Draft guideline

In operation: 01/05/2007–01/06/2016


Published: 30/04/2010


Published: 23/06/2005


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more